Drug Research
Vetter Further Invests €230M in New Production Building
Vetter, a global CDMO, is making additional investments as part of its long-lead goals for continued expansion and to support customer needs. The company is investing €230 million in its new production building, which is currently under construction at its...
Drug Research
Lonza to enhance commercial antibody-drug conjugate supply capacity
Lonza is planning to build a commercial-scale aseptic current good manufacturing practice (cGMP) filling line at its site in Stein, Switzerland. The new filling line will facilitate the aseptic filling of highly-potent antibody drug conjugates (ADCs) and lyophilisation under...
Press Releases
Turkish Cargo Chosen as The Best Air Cargo Brand of Europe
Turkish Cargo, successful brand of Turkish Airlines, is chosen as the best air cargo brand of Europe and received “Best Cargo Airline – Europe” award during the Air Cargo News Awards 2023 which was organized for the 39th time...
Press Releases
Vetter looks ahead to further expansions to meet supply chain demand
Committed to sustainable growth and long-term planning
Dedicated to making investments to support increased customer demand
Maintain efficiency and quality in development and manufacturing processes
Ravensburg, Germany, October 17, 2023: Vetter, a leading global Contract Development and Manufacturing Organization...
Press Releases
Cellares Announces Expanded Agreement with BMS to Include Second CAR-T Program in Cellares Technology Adoption Partnership Program
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that global biopharmaceutical company and cell therapy leader Bristol Myers Squibb will enter a second proof-of-concept tech transfer process for the...
Drug Research
Sygnature Discovery collaborates with Axol Bioscience to utilize human iPSC-derived microglial cells in high-content imaging drug discovery screening workflows
Sygnature Discovery, a world-leading integrated drug discovery provider and non-clinical solutions provider, has announced a scientific collaboration with human induced pluripotent stem cell (iPSC) experts, Axol Bioscience.
The collaboration aims to explore the incorporation of human iPSC-derived microglia into high-content...
Press Releases
Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions
Elsevier, a global leader in information and data analytics, has launched the new PharmaPendium, sharpening the translational view of a platform that combines extensive preclinical and clinical data, including complete Food and Drug Administration (FDA) and European Medicines Agency (EMA)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read